Jonathan Sheena - 20 Oct 2024 Form 4 Insider Report for Natera, Inc. (NTRA)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
22 Oct 2024, 21:35:10 UTC
Prior SEC filing
03 Oct 2024
Next SEC filing
12 Nov 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Tami Chen, Attorney-in-Fact
Filing notes and source

Key filing fact

Jonathan Sheena filed Form 4 for Natera, Inc. (NTRA) on 22 Oct 2024.

Key facts

  • This page summarizes Jonathan Sheena's Form 4 filing for Natera, Inc. (NTRA).
  • 4 reported transactions and 2 derivative rows are listed below.
  • Accepted by SEC: 22 Oct 2024, 21:35.

Change

  • Previous filing in this sequence was filed on 03 Oct 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NTRA transaction

Common Stock

Options Exercise

Transaction value
Shares
+190
Change %
+0.07%
Price
Shares after
282,231
Date
20 Oct 2024
Ownership
Direct
Footnotes
F1
NTRA transaction

Common Stock

Options Exercise

Transaction value
Shares
+143
Change %
+0.05%
Price
Shares after
282,374
Date
21 Oct 2024
Ownership
Direct
Footnotes
F1
NTRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
57,432
Date
20 Oct 2024
Ownership
By Caraluna 1 Trust
Footnotes
F2
NTRA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
57,432
Date
20 Oct 2024
Ownership
By Caraluna 2 Trust
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

NTRA transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-190
Change %
-17%
Price
$0.000000
Shares after
952
Date
20 Oct 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
190
Exercise price
Footnotes
F1, F3
NTRA transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-143
Change %
-50%
Price
$0.000000
Shares after
144
Date
21 Oct 2024
Ownership
Direct
Underlying class
Common Stock
Underlying amount
143
Exercise price
Footnotes
F1, F4
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 4 footnotes

Footnote F1

Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock.

Footnote F2

Held for the benefit of the beneficiaries of the trust. The Reporting Person disclaims beneficial ownership over such securities.

Footnote F3

The RSUs vest over four years. 25% of the RSUs vested on January 20, 2023 and the remaining shares vest in 12 equal quarterly installments thereafter.

Footnote F4

The RSUs vest over four years. 25% of the RSUs vested on January 21, 2022 and the remaining shares vest in 12 equal quarterly installments thereafter

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .